Trade Cassava Sciences, Inc. - SAVA CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.15 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 12.63 |
| Open | 12.98 |
| 1-Year Change | -35.84% |
| Day's Range | 12.98 - 14.84 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 12.67 | 1.04 | 8.94% | 11.63 | 12.80 | 11.55 |
| Jul 24, 2024 | 11.66 | -0.06 | -0.51% | 11.72 | 12.28 | 11.50 |
| Jul 23, 2024 | 11.99 | -0.66 | -5.22% | 12.65 | 13.14 | 11.92 |
| Jul 22, 2024 | 12.73 | 2.39 | 23.11% | 10.34 | 13.71 | 10.34 |
| Jul 19, 2024 | 10.03 | -0.17 | -1.67% | 10.20 | 10.61 | 9.89 |
| Jul 18, 2024 | 10.12 | 0.61 | 6.41% | 9.51 | 10.67 | 9.37 |
| Jul 17, 2024 | 9.49 | -0.21 | -2.16% | 9.70 | 10.49 | 8.77 |
| Jul 16, 2024 | 13.46 | 1.25 | 10.24% | 12.21 | 13.78 | 11.99 |
| Jul 15, 2024 | 12.26 | 0.77 | 6.70% | 11.49 | 12.30 | 11.49 |
| Jul 12, 2024 | 11.42 | 0.47 | 4.29% | 10.95 | 11.95 | 10.95 |
| Jul 11, 2024 | 10.92 | -0.28 | -2.50% | 11.20 | 12.32 | 10.85 |
| Jul 10, 2024 | 11.08 | -0.37 | -3.23% | 11.45 | 12.10 | 10.98 |
| Jul 9, 2024 | 11.50 | 1.73 | 17.71% | 9.77 | 12.30 | 9.70 |
| Jul 8, 2024 | 9.78 | -0.32 | -3.17% | 10.10 | 10.45 | 9.49 |
| Jul 5, 2024 | 10.05 | -0.40 | -3.83% | 10.45 | 11.04 | 9.95 |
| Jul 3, 2024 | 10.59 | -1.06 | -9.10% | 11.65 | 11.86 | 10.51 |
| Jul 2, 2024 | 11.72 | -0.04 | -0.34% | 11.76 | 12.58 | 11.25 |
| Jul 1, 2024 | 11.99 | 1.69 | 16.41% | 10.30 | 13.04 | 9.90 |
| Jun 28, 2024 | 12.18 | -6.60 | -35.14% | 18.78 | 18.96 | 8.70 |
| Jun 27, 2024 | 18.88 | 0.37 | 2.00% | 18.51 | 18.97 | 18.26 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Cassava Sciences Inc. Company profile
Cassava Science Inc is a clinical-stage biopharmaceutical company that specialises in detecting and treating Alzheimer’s disease, an incurable progressive neurologic disorder, which is . The company is listed on the Nasdaq under the ticker SAVA.
According to Cassava, over five million people in the US have Alzheimer’s. The company focuses on research and development to find new approaches for its treatment and diagnosis.
Cassava is developing Simufilam for the proposed treatment of Alzheimer's. According to the company, Simufilam is a proprietary oral drug candidate, developed in-house with academic collaborators. Simufilam, or PTI-125, is the company’s lead therapeutic product candidate. It’s currently (17 March) undergoing Phase 3 clinical studies.
SavaDx is the company’s investigational diagnostic for Alzheimer’s. According to the company, SavaDx is being developed to detect the disease with a simple blood test. However, SavaDx is still an early-stage product candidate and a lower priority than Simufilam, Cassava said.
Cassava was incorporated in 1998. It’s based in Austin, Texas, US. Remi Barbier has served as president, CEO and chairman of the board of directors since the company’s inception. Nadav Friedmann is the company’s chief medical officer. James Kupiec is the chief clinical development officer.
| Industry: | Bio Therapeutic Drugs |
6801 N Capital Of Texas Highway
Building 1; Suite 300
AUSTIN
TEXAS 78731
US
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com